What's new

Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 12, Status: Authorised

Jun 3, 2025 - 13:40
 0
Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag'...

Next Article

World Health Organization (WHO)

Related Posts

Human medicines European public assessment report (EPAR): Itovebi, inavolisib, Status: Opinion

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Advate, octocog alfa, Date of authorisation: 02/03/2004, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Clopidogrel Krka d.d. (previously Zopya), clopidogrel, Date of authorisation: 20/09/2009, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0